U.S. General Merchandise and Department Stores Stock News

NYSE:PRA
NYSE:PRAInsurance

ProAssurance (PRA) Margin Improvement Reinforces Bullish Narratives Despite Volatile Quarterly EPS

ProAssurance (PRA) opened 2026 with Q1 total revenue of US$262.6 million and basic EPS of US$0.16, while on a trailing twelve month basis revenue stood at US$1.1 billion with basic EPS of US$1.27. Over the past year, the company has seen trailing twelve month net income move from US$52.7 million in Q4 2024 to US$65.2 million in Q1 2026, with trailing net profit margins at 5.9% versus 3.7% a year earlier. This highlights a period of margin improvement that provides context for the latest...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

Masimo (MASI) Net Margin Recovery Reinforces Bullish Earnings Narratives In Q1 2026

Masimo (MASI) has opened Q1 2026 with revenue of US$403.6 million and basic EPS of US$1.08, while on a trailing 12 month basis EPS sits at US$4.08 and revenue at US$1.56 billion. This sets a clear earnings season snapshot for investors watching the stock around US$178.49. Over the past few quarters the company has seen revenue move from US$368.4 million in Q4 2024 to US$372.0 million in Q1 2025 and US$403.6 million in Q1 2026. Basic EPS has shifted from a loss of US$1.21 in Q4 2024 to US$0.87...
NYSE:HTGC
NYSE:HTGCCapital Markets

Hercules Capital (HTGC) Earnings Growth Slowdown Tests Bullish Margin Expansion Narrative

How Hercules Capital's Latest Numbers Set the Stage for the Current Debate Hercules Capital (HTGC) has opened 2026 with Q1 revenue of US$141.5 million and basic EPS of US$0.23, alongside trailing twelve month revenue of US$554.5 million and EPS of US$1.83 that reflect the strong 49.4% earnings growth recorded over the past year. Over recent quarters the company has seen revenue move from US$119.5 million in Q1 2025 to US$141.5 million in Q1 2026, with quarterly EPS ranging from US$0.29 to...
NYSE:ALV
NYSE:ALVAuto Components

Is Autoliv (ALV) Pricing In Its Strong Multi‑Year Share Price Performance?

Investors may be wondering whether Autoliv stock now reflects its underlying value, or if the recent attention has left some mispricing on the table. The share price recently closed at US$121.25, with returns of 7.0% over 7 days, 15.2% over 30 days, 33.2% over 1 year, 49.8% over 3 years, 44.3% over 5 years and a small year to date loss of 0.7%. Recent coverage has focused on Autoliv as a key player in vehicle safety systems. This helps frame how investors are thinking about its earnings...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

Is It Too Late To Consider StoneX Group (SNEX) After Its Strong Recent Share Price Run?

Wondering whether StoneX Group stock still offers value after its strong run, or if you might be late to the party? This article breaks down what the current price could mean for you. At a recent close of US$106.39, the stock shows returns of 2.6% over 7 days, 24.3% over 30 days, 63.9% year to date and 69.5% over 1 year, with a very large 5 year return of 436.3%. Recent news coverage has focused on StoneX Group's role as a global financial services company and its position in capital...
NYSEAM:SEB
NYSEAM:SEBFood

Seaboard (SEB) Margin Rebound to 5.9% Challenges Longstanding Earnings Bear Case

Seaboard's Q1 2026 Earnings Snapshot Seaboard (SEB) opened 2026 with Q1 total revenue of US$2.4b, basic EPS of US$124.24 and net income of US$119m, setting a fresh reference point against last year’s sharp earnings rebound. Over recent quarters the company has seen quarterly revenue move from US$2.316b in Q1 2025 to around the US$2.4b range in Q1 2026. Basic EPS shifted from US$32.95 to US$124.24. Trailing twelve month EPS reached US$606.79 alongside net income of US$583m on US$9.83b of...
NYSE:CTVA
NYSE:CTVAChemicals

Corteva (CTVA) Q1 EPS Beat Strengthens Bullish Margin Narrative Despite Valuation Debate

Q1 2026 headline results and setup Corteva (CTVA) opened 2026 with Q1 revenue of US$4.9 billion and basic EPS of US$1.07, with trailing twelve month net income of US$1.25 billion giving investors a fuller view of the current earnings run rate. The company reported quarterly revenue of US$4.42 billion in Q1 2025 and US$4.91 billion in Q1 2026, while basic EPS moved from US$0.97 to US$1.07 over the same period as trailing net profit margins held close to 7%. With earnings growth forecasts...
NYSE:BBWI
NYSE:BBWISpecialty Retail

Is Bath & Body Works (BBWI) Pricing Reflect Its Recent Share Price Swings?

Wondering if Bath & Body Works at around US$19.20 is a bargain or a value trap? This article focuses squarely on what the current price may be implying about the stock. The stock has risen 4.7% over the last week and 6.0% over the last month, yet year to date it shows a 7.4% decline and the 1 year return stands at 34.8% lower. This pattern may catch the eye of value focused investors. Recent coverage around specialty retail and consumer discretionary spending has put companies like Bath &...
NYSE:PLOW
NYSE:PLOWMachinery

Is It Too Late To Consider Douglas Dynamics (PLOW) After Its 84% One Year Surge?

Some investors may be considering whether Douglas Dynamics at around US$45.42 is still offering value after a strong run, or whether much of the opportunity is already reflected in the current share price. The stock has recorded returns of 2.8% over 7 days, 8.1% over 30 days, 37.7% year to date and 83.6% over 1 year. This puts recent price action front and center for anyone weighing the balance between potential and risk. Recent coverage has highlighted Douglas Dynamics as a Machinery sector...
NasdaqGS:INNV
NasdaqGS:INNVHealthcare

InnovAge Holding (INNV) Q3 Loss Deepens Despite Revenue Growth Challenging Bullish Profitability Narratives

InnovAge Holding (INNV) has posted a mixed Q3 2026 result, with revenue at US$251.9 million and a basic EPS loss of US$0.22 alongside net income of US$29.5 million in the red. The company’s revenue increased from US$218.1 million in Q3 2025 to US$251.9 million in Q3 2026, while quarterly EPS moved from a loss of US$0.08 to a loss of US$0.22 over the same period. This sets up a narrative that now focuses on how quickly margins can be repaired to align with the growth in the top line. See our...
NYSE:VNT
NYSE:VNTElectronic

Vontier Showcases Multi Energy Fleet Platform And Draws Valuation Attention

Vontier (NYSE:VNT) highlighted its multi energy fleet technology strategy at ACT Expo 2026. The company presented an integrated platform that combines traditional and new energy refueling, EV management, diagnostics, payment security, and telematics. The event showcased new solutions aimed at supporting fleet decarbonization and digital transformation. For investors tracking the fleet and mobility sector, Vontier sits at the intersection of hardware, software, and services for...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Phibro Animal Health (PAHC) Is Up 11.4% After Strong Q3 Earnings And New Sustainability Push – What's Changed

Phibro Animal Health Corporation has reported its third-quarter 2026 results, with sales of US$383.54 million and net income of US$24.02 million, alongside the launch of its Sustainable Solutions Platform and Verratain™ low‑carbon feed products in partnership with VAXA Technologies. The combination of stronger earnings and a companywide push into emissions‑focused feed ingredients suggests Phibro is tying profitability more closely to sustainability trends across animal protein and petfood...
NasdaqCM:OCGN
NasdaqCM:OCGNBiotechs

Ocugen (OCGN) Valuation Check As Loss-Making Q1 2026 And US$103.5m Convertible Notes Reset Expectations

Earnings and convertible notes set the stage for Ocugen stock Ocugen (OCGN) is back in focus after reporting first quarter 2026 results and closing a US$103.5 million convertible note offering, a combination that puts both its cash needs and capital structure in the spotlight. See our latest analysis for Ocugen. The recent 1 day share price return of 2.35% decline and 7 day share price return of 13.39% decline suggest some short term profit taking after the earnings release and convertible...
NasdaqCM:ONCY
NasdaqCM:ONCYBiotechs

Oncolytics Biotech’s Pelareorep Data Reshapes Colorectal Cancer And Investor Outlook

Oncolytics Biotech reported new durability and response data for its pelareorep therapy in RAS-mutant MSS metastatic colorectal cancer. The pelareorep-based regimen outperformed historical benchmarks in second-line treatment, with longer median duration of response and higher objective response rates. The company has initiated enrollment in a Phase 2 randomized study and is in active discussions with the FDA on a potential accelerated approval pathway. For investors watching NasdaqCM:ONCY,...
NasdaqGS:AUR
NasdaqGS:AURSoftware

Aurora Innovation’s First Driverless Contract Tests Autonomous Freight Economics

Aurora Innovation (NasdaqGS:AUR) has signed its first commercial contract for fully driverless long haul trucking with McLane Company. The partnership will use autonomous trucks to run driverless routes in Texas for a major national distributor. Aurora plans to scale to 200 fully driverless trucks and broaden its US route network by year end. Aurora Innovation focuses on autonomous driving technology, with trucking as a key commercial application. The McLane agreement moves the company from...
NasdaqGS:BJRI
NasdaqGS:BJRIHospitality

BJ’s Restaurants (BJRI) Margin Improvement Tests Bullish Earnings Growth Narrative In Q1 2026

BJ's Restaurants (BJRI) opened 2026 with Q1 revenue of US$358.1 million and basic EPS of US$0.43, alongside trailing 12 month revenue of about US$1.4b and EPS of US$2.05 that reflect reported earnings growth of 98.1% year over year and a 5 year annualized earnings growth rate of 66.7%. Over the last few quarters the company has seen revenue move from US$347.9 million and EPS of US$0.59 in Q1 2025 to US$355.4 million and EPS of US$0.60 in Q4 2025, before landing at the current Q1 2026 levels...
NYSE:LOMA
NYSE:LOMABasic Materials

Loma Negra (NYSE:LOMA) Q1 EPS Rebound Tests Bearish Margin Compression Narrative

Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE:LOMA) opened 2026 with Q1 results that put revenue at about ARS 218.7b and basic EPS at ARS 351.37, setting a clear marker for how the year is starting to shape up. Over the past few quarters, the company has seen revenue move from about ARS 279.4b in Q4 2024 to ARS 172.9b in Q1 2025 and then to ARS 270.6b in Q4 2025. Basic EPS shifted from ARS 360.89 to ARS 195.07 and then to ARS 64.39, so this latest print lands against a...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

EyePoint (EYPT) Q1 Loss Near US$85 Million Tests Bullish DURAVYU Narratives

EyePoint Pharmaceuticals (EYPT) opened 2026 with Q1 revenue of US$0.7 million, a basic EPS loss of US$0.99 per share and a net income loss of US$84.8 million, setting a clear tone for how profitability is tracking into the new year. The company has seen quarterly revenue move from US$24.5 million in Q1 2025 to US$0.7 million in Q1 2026, while quarterly basic EPS shifted from a loss of US$0.65 to a loss of US$0.99. The latest print keeps the focus squarely on how much cash the business is...
NYSE:NC
NYSE:NCOil and Gas

NACCO Industries (NC) Margin Compression Reinforces Bearish Earnings Narratives After Q1 2026 Results

NACCO Industries (NC) opened 2026 with Q1 revenue of US$62.8 million and basic EPS of US$1.18, setting a clear marker against a share price of US$50.74. Over recent quarters, the company has reported revenue of US$65.6 million in Q1 2025, US$70.4 million in Q4 2024 and US$62.8 million in Q1 2026, while quarterly EPS moved from US$0.67 in Q1 2025 to US$1.04 in Q4 2024 and US$1.18 in Q1 2026. This sequence gives investors a clearer view of how revenue and earnings are tracking through the...
NYSE:LVS
NYSE:LVSHospitality

Las Vegas Sands Credit Upgrade Reshapes Debt Costs And Investor Trade Offs

S&P Global Ratings upgraded Las Vegas Sands (NYSE:LVS) and its Macau unit to BBB from BBB-. The upgrade follows what S&P described as a disciplined financial policy, limited new development plans, and a recovery in Macau operations. Soon after the upgrade, Las Vegas Sands issued US$1b in new senior notes intended to refinance existing debt on improved terms. S&P also pointed to the potential for higher shareholder rewards, including the possibility of further share buybacks. For you as an...
NYSE:SLQT
NYSE:SLQTInsurance

SelectQuote (SLQT) Returns To Quarterly Profit But Volatile EPS Tests Bullish Margin Story

SelectQuote (SLQT) just reported a busy Q2 2026, with total revenue of US$537.1 million and net income of US$51.2 million, which translated to basic EPS of US$0.27. The company’s quarterly revenue had previously stood at US$481.1 million with EPS of US$0.31 in Q2 2025, followed by a mix of losses and profits in subsequent periods, before arriving at the current quarter’s figures. For you as an investor, this latest report highlights a balance between improving profitability on one hand and...
NasdaqGM:WLFC
NasdaqGM:WLFCTrade Distributors

Is It Too Late To Consider Willis Lease Finance (WLFC) After Its Recent Share Price Surge?

If you are wondering whether Willis Lease Finance at around US$229 per share still offers value, you are not alone in asking what the current price really reflects. The stock has recently posted returns of 19.6% over 7 days, 30.2% over 30 days, 70.8% year to date and 72.3% over 1 year, with very large gains over 3 and 5 years. Recent headlines have focused on Willis Lease Finance within the capital goods and aircraft leasing space, highlighting how investors are paying closer attention to...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

A Look At Phathom Pharmaceuticals (PHAT) Valuation After Narrower Losses And Reaffirmed Profitability Timeline

Phathom Pharmaceuticals (PHAT) recently reported first quarter results showing a net loss of US$30.37 million, alongside reaffirmed 2026 guidance that includes an operating profitability target beginning in the third quarter. See our latest analysis for Phathom Pharmaceuticals. The stock’s recent 12.62% 1 month share price return, alongside a 7.56% 7 day gain, contrasts with a 19.35% year to date share price decline. At the same time, the 1 year total shareholder return above 400% highlights...
NYSE:FND
NYSE:FNDSpecialty Retail

Is It Time To Reconsider Floor & Decor (FND) After A 30% One Year Share Price Drop

If you are wondering whether Floor & Decor Holdings at around US$51 a share is attractively priced or a potential value trap, the starting point is understanding how the current market price lines up against different measures of value. The stock has recently moved 7.0% over the last week and 3.3% over the last month, while the year to date return sits at a 19.0% decline and the 1 year return at a 30.5% decline, which may catch the eye of investors weighing up risk and recovery...